No Prescription |
 |
 | ||
|
ZAART H Hyzaar |
|
| ||
No Prescription » Prescription Drugs 17 » ZAART H Hyzaar The combination of losartan and hydrochlorothiazide is used to treat high blood pressure. Losartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain chemicals that tighten the blood vessels so blood flows more smoothly. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used to treat congestive heart failure and to help protect the kidneys from damage due to diabetes. Losartan has been used to lower the risk of strokes in patients with high blood pressure and an enlarged heart.How to use Zaart OralThis medicine comes with a Patient Information Leaflet. Read it carefully. Ask your doctor nurse or pharmacist any questions that you may have about this medicine.Take this medication by mouth usually once daily or as directed by your doctor. You may take this drug with or without food. Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same time each day.Drink adequate fluids to prevent from becoming dehydrated. If you are on restricted fluid intake consult your doctor for further instructions.Do not take potassium supplements or salt substitutes containing potassium without talking to your doctor or pharmacist first. This medicine can infrequently raise or lower your potassium blood levels which rarely can cause serious side effects such as muscle weakness/cramping or very slow heartbeats. Tell your doctor immediately if these effects occur.The dosage is based on your medical condition and response to therapy. For the treatment of high blood pressure it may take 3 to 6 weeks before the full benefit of this drug occurs.It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick.If you are also taking cholestyramine or colestipol take losartan/hydrochlorothiazide at least 2 hours before either of these drugs.Zaart Oral is used to treat the following:High Blood Pressure Severe Uncontrolled High Blood Pressure Hypertension with Left Ventricular Hypertrophy Buy ZAART H Hyzaar and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About ZAART H Hyzaar: Product Type: Prescription Drugs 17 ZAART-H ( Hyzaar Generic Losartan/HCTZ ) ZAART-H (Hyzaar Generic Losartan/HCTZ) Hyzaar Generic Losartan/HCTZ 50 mg / 12.5 mg Hyzaar Generic Losartan/HCTZ ZAART-H
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
